dual glp 1 and gip receptor agonist The Sustained Effects of a GIP/GLP-1 Agonist, NNC0090-2746, in Patients with Type 2 Diabetes Independent Nurse - GLP-1 and

The clinical trials showing lean mass reductions were not conducted on people doing three sets of Romanian deadlifts and hitting 1.6 grams of protein per kilogram

In my survey of 2232 of my readers with Hashimotos , 88 percent saw improvement in energy from B12 supplementation

Very professional and easy to navigate website

The Philippines FDA has issued a formal warning against high-dose unsupervised cosmetic IV glutathione, and a 2025 case series in the International Journal of Dermatology documented liver function abnormalities in approximately half of high-dose IV-treated participants in unmonitored settings, which is precisely why the DermaVue protocol restricts dosing to the 400 to 1200 mg clinical range and enforces hepatic monitoring

No, retatrutide remains in phase 3 trials as of January 2026 and is not FDAapproved

Botox is a prescription drug